By NewsDesk  @infectiousdiseasenews Biopharmaceutical company focused on developing and commercializing vaccines, Dynavax Technologies Corporation, and the U.S. Department of Defense (DOD) announced...

Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on discovering and developing transformative biologic therapies and vaccines, today announced positive preclinical data...

Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, and Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing...

On Thursday, Dynavax Technologies Corporation announced that the U.S. Food and Drug Administration (FDA) approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection...